MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202648082250 A) filed by Acuitas Therapeutics Inc.; and Curevac Se on July 03, 2026, for Lipid Nanoparticle Mrna Vaccines.
Inventors include Baumhof, Patrick; Fotin-Mleczek, Mariola; Heidenreich, Regina; Hope, Michael J.; Jasny, Edith; Lazzaro, Sandra; Lin, Paulo Jia Ching Number; Lutz, Johannes; Mui, Barbara; Petsch, Benjamin Filed On; Rauch, Susanne; Schwendt, Kim Ellen; and Tam, Ying.
The application for the patent was published on July 10, 2026, under issue no. 28/2026.
Abstract: ABSTRACT LIPID NANOPARTICLE MRNA VACCINES The invention relates to mRNA comprising lipid nanoparticles and their medical uses. The lipid nanoparticles of the present invention comprise a cationic lipid according to formula (I), (II) or (III) and/or a PEG lipid according to formula (IV), as well as an mRNA compound comprising an mRNA sequence encoding an antigenic peptide or protein. The invention further relates to the use of said lipid nanoparticles as vaccines or medicaments, in particular with respect to influenza or rabies vaccination. [Fig.1A & Fig.1B]
Disclaimer: Curated by HT Syndication.
